Our finding that tumor cell surface molecules of the B7 family implicated in immunoevasion mechanisms were recognised by the adenoviral vector Ad5FB4 offered novel opportunities for cancer therapy, using intrinsically B7-targeted Ad5FB4 vectors for therapeutic gene transfer. The gene discussed is CD80; the disease is cancer.